Halozyme Therapeutics | HALO - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Amarin USD 23.17M 961K 2025-12
Amgen USD 5.87B 1.02B 2026-03
Baxter International USD 1.14B 251M 2026-06
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cytokinetics USD 23.03M 3.84M 2026-06
DBV Technologies USD 2.77M 33.21M 2025-09
Eli Lilly USD 16.22B 301.7M 2026-03
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Intrexon USD -297K 167K 2024-06
Ionis Pharmaceuticals USD 265M 22M 2026-06
MannKind USD 7.77M 60.56M 2026-06
Minerva Neurosciences -4.27M 26.79M 2024-12
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Pfizer USD -248M 11.29B 2026-06
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
United Therapeutics USD 683.8M 35.7M 2026-06
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12